These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1088916)

  • 1. Efficacy of an antihypertensive agent. Comparison of methyldopa and hydrochlorothiazide in combination and singly.
    McMahon FG
    JAMA; 1975 Jan; 231(2):155-8. PubMed ID: 1088916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the antihypertensive action of methyldopa alone or in combination with hydrochlorothiazide].
    Mattar E; Cruz HM; Cruz J
    Rev Paul Med; 1971 Jul; 78(1):19-30. PubMed ID: 5164628
    [No Abstract]   [Full Text] [Related]  

  • 3. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrochlorothiazide plus methyldopa in the treatment of isolated systolic hypertension in the elderly.
    Boyles PW
    Clin Ther; 1984; 6(6):793-9. PubMed ID: 6509462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prazosin in hypertension with and without methyldopa.
    Kochar MS; Zeller JR; Itskovitz HD
    Clin Pharmacol Ther; 1979 Feb; 25(2):143-8. PubMed ID: 365428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive drugs in combination: Effects of methyldopa on thiazide-induced changes in renal hemodynamics and plasma renin activity.
    Kaplan NM
    Arch Intern Med; 1975 May; 135(5):660-3. PubMed ID: 802630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of debrisoquine and methyldopa in hypertension.
    Pörsti P
    Ann Clin Res; 1976 Feb; 8(1):55-62. PubMed ID: 779588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe.
    Stein CM; Neill P; Mwaluko GM; Kusema T
    S Afr Med J; 1990 Mar; 77(5):243-5. PubMed ID: 2107581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyldopa-hydrochlorothiazide therapy in hypertensive geriatric patients.
    Corman LA; Skversky NJ
    J Am Geriatr Soc; 1973 Jan; 21(1):36-9. PubMed ID: 4682564
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of single-dose methyldopa and diuretic on BP and left ventricular mass.
    Weinstein M; Hilewitz H; Rogel S
    Arch Intern Med; 1984 Aug; 144(8):1629-32. PubMed ID: 6235790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive effectiveness and tolerability of a combination of methyldopa and hydrochlorothiazide with and without potassium supplementation].
    De Giorgio LA; Innocenti F; Bartolomei GC
    G Clin Med; 1979 Sep; 60(9):729-47. PubMed ID: 262645
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
    Chalmers JP; Korner PI; Tiller DJ; Bune AJ; Steiner JD; West MJ; Wing LM; Uther JF
    Med J Aust; 1976 May; 1(18):650-3. PubMed ID: 781495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of guanethidine and methyldopa in essential hypertension: a controlled study.
    Glazer N
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):249-56. PubMed ID: 805019
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multicenter study of the efficacy of 3 antihypertensive regimens: captopril + hydrochlorothiazide, oxprenolol + hydrochlorothiazide, and alphamethyldopa + hydrochlorothiazide].
    Ocón J; Oliván J; Garrido Peralta M; Ruilope L; Rodicio JL; Seco Vasco J; Rodríguez Alvarez J; Gras X
    Med Clin (Barc); 1985 Nov; 85(15):617-21. PubMed ID: 3908851
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors and quality of life: the European trial.
    Hill JF; Bulpitt CJ; Fletcher AE
    J Hypertens Suppl; 1985 Nov; 3(2):S91-4. PubMed ID: 3003305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double blind evaluation of indoramin and methyldopa in thiazide treated hypertensive patients.
    Yajnik VH; Patel SC
    Indian Heart J; 1978; 30(1):51-6. PubMed ID: 359454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.